YANG TAIYINofficer: SVP, Pharm Dev & Mfgofficer: SVP, Pharm Dev & Mfg
Common Stock
20,000
$61.18
$1,223,540
Option
MARTIN JOHN Cdirectordirector
Common Stock
120,000
$3.27
$391,920
Option
MARTIN JOHN Cdirectordirector
Non-Qualified Stock Option (right to buy)
120,000
$3.27
$391,920
Sale
MARTIN JOHN Cdirectordirector
Common Stock
120,000
$61.73
$7,407,720
Sale
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
20,000
$60.88
$1,217,500
Sale
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
30,000
$60.25
$1,807,500
Option
BISCHOFBERGER NORBERT Wofficer: EVP, R&D and CSOofficer: EVP, R&D and CSO
Non-Qualified Stock Option (right to buy)
136,488
$11.92
$1,626,664
Option
BISCHOFBERGER NORBERT Wofficer: EVP, R&D and CSOofficer: EVP, R&D and CSO
Common Stock
136,488
$11.92
$1,626,664
Showing 2700 to 2750 of 3053 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.